Description
Long-acting growth hormone-releasing hormone (GHRH) analog
CJC-1295 with DAC is a lab-engineered peptide aimed at stimulating prolonged growth hormone release. Through interaction with GHRH receptors, promotes elevated levels of both growth hormone and IGF-1 – key drivers of muscle development, fat reduction, and cellular regeneration. DAC technology significantly extends the peptide’s half-life, allowing for sustained hormonal elevation. Benefits include improving body composition, enhancing recovery, and promoting anti-aging mechanisms.
References
- Teichman SL, et al. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. J Clin Endocrinol Metab. 2006;91(3):799-805. PMID: 16352683 | DOI: 10.1210/jc.2005-1536
- Memdouh S, et al. Advances in the detection of growth hormone releasing hormone synthetic analogs. Drug Test Anal. 2021;13(11-12):1871-1887. PMID: 34665524 | DOI: 10.1002/dta.3183
- Timms M, et al. An immuno polymerase chain reaction screen for the detection of CJC-1295 and other growth-hormone-releasing hormone analogs in equine plasma. Drug Test Anal. 2019;11(6):804-812. PMID: 30489688 | DOI: 10.1002/dta.2554
